Clinical Trials Update: July 29, 2003
Breast Cancer Diabetes - Type 2 Skin Cancer
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A study to evaluate an investigational medication in preventing bone loss in postmenopausal women who are receiving letrozole therapy for the treatment of breast cancer. Postmenopausal female volunteers with breast cancer who have not had prior treatment with letrozole (Femara) and who do not have metastasis to other parts of the body may be eligible. Research site located in Royal Oak, Michigan.
Diabetes - Type 2
A research study to determine the effectiveness of two marketed medications in reducing protein in the urine in patients with Type 2 diabetes. Volunteers who have Type 2 diabetes, high blood pressure and elevated protein in the urine may be eligible. Research site located in Rochester, New York.
A study to evaluate the ability of an investigational medication to prevent or slow the recurrence of melanoma. Volunteers with Stage III or Stage IV melanoma who have had all clinically-detectable disease surgically removed may be eligible. Research site located in Seattle, Washington.
Copyright 2003 CenterWatch. All rights reserved.